跳至主要内容
临床试验/ISRCTN47228763
ISRCTN47228763已完成不适用

Influence of different types of dialysis membranes on parameters of chronic inflammatio

Gambro SAS (France)0 个研究点目标入组 180 人开始时间: 2006年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Medically stable end-stage renal disease patients on hemodialysis for 6 months or more
  • 2. Age =18 years
  • 3. C-reactive protein between 5 and 50 mg/l maximum one week before inclusion
  • 4. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) serologies negative
  • 5. Not under guardianship
  • 6. AgHbs negative
  • 7. Absence of vascular access thrombosis
  • 8. Absence of clinically identifiable cause of chronic inflammation
  • 9. Treatment in a dialysis unit providing water quality according to the European Pharmacopoeia
  • 10. Statin medication allowed, but no introduction or modification during the study
  • 11. Hemodialysis blood flow rates between 200 and 500 ml/min possible
  • 12. Dialysis frequency 3-4 per week

排除标准

  • 1. Age >75 years
  • 2. Known pregnancy
  • 3. Severe comorbidities with life expectancy <1 year
  • 4. Cancer except skin cancer
  • 5. Severe digestive pathologies
  • 6. Chronic inflammatory diseases
  • 7. Medication interfering with nutritional or inflammatory status
  • 8. Treatment or intention to treat with immunosuppressive medication
  • 9. Dialysis dose Kt/V <1.2, and dialysis time <10 hours per week
  • 10. Treatment with hemofiltration or hemodiafiltration
  • 11. Participation in another study during the preceding 30 days
  • 12. Physically or mentally disabled patients

研究者

发起方
Gambro SAS (France)

相似试验